MFT
ATRC icon

Moisand Fitzgerald Tamayo’s AtriCure ATRC Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16
Closed -$1K – 699
2022
Q2 		$1K Sell
16
-16
-50% -$758 ﹤0.01% 466
2022
Q1 		$2K Buy
+32
New +$2.07K ﹤0.01% 362

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Moisand Fitzgerald Tamayo's ATRC Position: Q3 2022 in Review

Moisand Fitzgerald Tamayo sold out of AtriCure (ATRC) in Q3 2022, closing a stake of 16 shares — an estimated $1K sold.

Moisand Fitzgerald Tamayo first reported a position in ATRC in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 214 funds tracked by Wall St. Rank hold ATRC as of Q3 2022.

  • Moisand Fitzgerald Tamayo reported no remaining AtriCure position as of Q3 2022 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 16 AtriCure shares in Q3 2022, an estimated $1K.
  • Moisand Fitzgerald Tamayo first reported a position in AtriCure in Q1 2022 and held it in 2 quarters.
  • Moisand Fitzgerald Tamayo's AtriCure position peaked at $2K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held AtriCure as of Q3 2022.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q3 2022, filed 26 Oct 2022.